BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 8245985)

  • 1. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis.
    Bowling AC; Schulz JB; Brown RH; Beal MF
    J Neurochem; 1993 Dec; 61(6):2322-5. PubMed ID: 8245985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic dysfunction in familial, but not sporadic, amyotrophic lateral sclerosis.
    Browne SE; Bowling AC; Baik MJ; Gurney M; Brown RH; Beal MF
    J Neurochem; 1998 Jul; 71(1):281-7. PubMed ID: 9648876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis.
    Ferrante RJ; Browne SE; Shinobu LA; Bowling AC; Baik MJ; MacGarvey U; Kowall NW; Brown RH; Beal MF
    J Neurochem; 1997 Nov; 69(5):2064-74. PubMed ID: 9349552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superoxide dismutase concentration and activity in familial amyotrophic lateral sclerosis.
    Bowling AC; Barkowski EE; McKenna-Yasek D; Sapp P; Horvitz HR; Beal MF; Brown RH
    J Neurochem; 1995 May; 64(5):2366-9. PubMed ID: 7722523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in anti-oxidative defence enzymes in erythrocytes from sporadic amyotrophic lateral sclerosis (SALS) and familial ALS patients.
    Nikolić-Kokić A; Stević Z; Blagojević D; Davidović B; Jones DR; Spasić MB
    Clin Chem Lab Med; 2006; 44(5):589-93. PubMed ID: 16681429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superoxide dismutase activity in lymphoblastoid cells from motor neurone disease/amyotrophic lateral sclerosis (MND/ALS) patients.
    Garofalo O; Figlewicz DA; Thomas SM; Butler R; Lebuis L; Rouleau G; Meininger V; Leigh PN
    J Neurol Sci; 1995 May; 129 Suppl():90-2. PubMed ID: 7595631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation.
    Tan CF; Eguchi H; Tagawa A; Onodera O; Iwasaki T; Tsujino A; Nishizawa M; Kakita A; Takahashi H
    Acta Neuropathol; 2007 May; 113(5):535-42. PubMed ID: 17333220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis.
    Deng HX; Zhai H; Bigio EH; Yan J; Fecto F; Ajroud K; Mishra M; Ajroud-Driss S; Heller S; Sufit R; Siddique N; Mugnaini E; Siddique T
    Ann Neurol; 2010 Jun; 67(6):739-48. PubMed ID: 20517935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOD1 mutations in amyotrophic lateral sclerosis. Results from a multicenter Italian study.
    Battistini S; Giannini F; Greco G; Bibbò G; Ferrera L; Marini V; Causarano R; Casula M; Lando G; Patrosso MC; Caponnetto C; Origone P; Marocchi A; Del Corona A; Siciliano G; Carrera P; Mascia V; Giagheddu M; Carcassi C; Orrù S; Garrè C; Penco S
    J Neurol; 2005 Jul; 252(7):782-8. PubMed ID: 15789135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis.
    Menzies FM; Cookson MR; Taylor RW; Turnbull DM; Chrzanowska-Lightowlers ZM; Dong L; Figlewicz DA; Shaw PJ
    Brain; 2002 Jul; 125(Pt 7):1522-33. PubMed ID: 12077002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis.
    Wicks P; Abrahams S; Papps B; Al-Chalabi A; Shaw CE; Leigh PN; Goldstein LH
    J Neurol; 2009 Feb; 256(2):234-41. PubMed ID: 19252762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High metabolic level in patients with familial amyotrophic lateral sclerosis.
    Funalot B; Desport JC; Sturtz F; Camu W; Couratier P
    Amyotroph Lateral Scler; 2009 Apr; 10(2):113-7. PubMed ID: 18792852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of mitochondrial oxidative phosphorylation in skin fibroblasts of SALS and FALS patients is rescued by in vitro treatment with ROS scavengers.
    Debska-Vielhaber G; Miller I; Peeva V; Zuschratter W; Walczak J; Schreiber S; Petri S; Machts J; Vogt S; Szczepanowska J; Gellerich FN; Hermann A; Vielhaber S; Kunz WS
    Exp Neurol; 2021 May; 339():113620. PubMed ID: 33497646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cu/Zn superoxide dismutase activity at different ages in sporadic amyotrophic lateral sclerosis.
    Fiszman ML; Borodinsky LN; Ricart KC; Sanz OP; Sica RE
    J Neurol Sci; 1999 Jan; 162(1):34-7. PubMed ID: 10064166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and metal content in blood and cerebrospinal fluid of amyotrophic lateral sclerosis patients with and without a Cu, Zn-superoxide dismutase mutation.
    Ihara Y; Nobukuni K; Takata H; Hayabara T
    Neurol Res; 2005 Jan; 27(1):105-8. PubMed ID: 15829169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes.
    Millecamps S; Boillée S; Le Ber I; Seilhean D; Teyssou E; Giraudeau M; Moigneu C; Vandenberghe N; Danel-Brunaud V; Corcia P; Pradat PF; Le Forestier N; Lacomblez L; Bruneteau G; Camu W; Brice A; Cazeneuve C; Leguern E; Meininger V; Salachas F
    J Med Genet; 2012 Apr; 49(4):258-63. PubMed ID: 22499346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HtrA2/Omi-immunoreactive intraneuronal inclusions in the anterior horn of patients with sporadic and Cu/Zn superoxide dismutase (SOD1) mutant amyotrophic lateral sclerosis.
    Kawamoto Y; Ito H; Kobayashi Y; Suzuki Y; Akiguchi I; Fujimura H; Sakoda S; Kusaka H; Hirano A; Takahashi R
    Neuropathol Appl Neurobiol; 2010 Jun; 36(4):331-44. PubMed ID: 20202124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased sensitivity of fibroblasts from amyotrophic lateral sclerosis patients to oxidative stress.
    Aguirre T; Van Den Bosch L; Goetschalckx K; Tilkin P; Mathijs G; Cassiman JJ; Robberecht W
    Ann Neurol; 1998 Apr; 43(4):452-7. PubMed ID: 9546325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics of ALS in Italian families.
    Gellera C
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Mar; 2 Suppl 1():S43-6. PubMed ID: 11465924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOD1 activity and protective factors in familial ALS patients with L84F SOD1 mutation.
    Curti D; Rognoni F; Alimonti D; Malaspina A; Feletti F; Tessera S; Finotti N; Rehak L; Mazzini L; Zerbi F; Poloni TE; Ceroni M
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Sep; 3(3):115-22. PubMed ID: 12495572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.